Dividends Inside Welcome to Dividends Inside
Welcome to Dividends Inside!
The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.
Welcome to Dividends Inside!
The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.
Danaher Corporation
DHR
$167.04 (+ $2.63 + 1.60%)
Last updated: Previous Close (2026-05-19)
About the Company
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services globally, with a primary focus on the United States, China, and other international markets. Operating through three key segments—Biotechnology, Life Sciences, and Diagnostics—the company provides bioprocessing technologies, consumables, and solutions that accelerate therapeutic development and manufacturing, including cell culture media, chromatography resins, filtration systems, and single-use hardware for full manufacturing suites. Its Life Sciences division supports advanced research tools, while Diagnostics offers essential testing and healthcare filtration solutions. Originally founded in 1969 and transformed through strategic acquisitions and divestitures, such as the 2023 spin-off of its environmental solutions into Veralto, Danaher now concentrates on scientific instruments and consumables in the diagnostics and research sector. Employing around 62,000 to 63,000 people under CEO Rainer Blair, Danaher plays a pivotal role in the healthcare and life sciences industries, driving innovation in biopharma production and medical diagnostics with a strong emphasis on recurring revenue streams.
Price History
Latest News for DHR
Here Are Friday’s Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More
Pre-Market Stock Futures: Futures are trading sharply lower as we get set to end one of the most exciting weeks on Wall Street in 25 years. Positive meetings in China with President Trump, who brought his CEO contingent and Elon Musk, and President Xi, massive upside earnings and forward guidance from an OG tech and ... Here Are Friday’s Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, a
10 Quality Stocks That Hit New Lows This Week—and Look Like Bargains
Even as tech surges, many other sectors in the market are trading at surprisingly attractive prices.
Jim Cramer Discusses the Performance of Danaher and Its Peers
Danaher Corporation (NYSE:DHR) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer called it a “one-time excellent company,” as he said: For instance, Danaher, another one-time excellent company, has seen the stock just get pulverized after not-so-great quarters, or I […]
Is Danaher Corporation (DHR) A Good Stock To Buy Now?
Is DHR a good stock to buy? We came across a bullish thesis on Danaher Corporation on r/ValueInvesting by One_Complaint_2945. In this article, we will summarize the bulls’ thesis on DHR. Danaher Corporation’s share was trading at $174.04 as of May 4th. DHR’s trailing and forward P/E were 33.94 and 20.66 respectively according to Yahoo Finance. Danaher […]
Danaher Digital Transformation Strategy Analysis Report 2026: Technology Focus and Initiatives, Partnerships and Acquisitions, ICT Budget & Contracts, Tech Ecosystem
Danaher Corp leverages technology and digital transformation in life sciences, diagnostics, and biotechnology. Opportunities lie in innovation initiatives, strategic partnerships, and acquisitions to advance diagnostics and biological medicine production, emphasizing DNA, RNA, and protein research.Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Danaher Corp. - 2026" company profile has been added to ResearchAndMarkets.com's offering. The report provides detailed i
Is Danaher (DHR) Pricing Look Interesting After Recent Life Sciences Portfolio Focus News
If you are wondering whether Danaher's current share price reflects its underlying worth, the recent performance gives plenty to think about. The stock closed at US$175.66, with returns of a 1.8% decline over 7 days, 8.0% decline over 30 days, 23.8% decline year to date, 9.2% decline over 1 year, 12.7% decline over 3 years, and 19.7% decline over 5 years. Recent news around Danaher includes ongoing attention on its portfolio positioning and market role in life sciences tools, which can shape...